Current and Future Perspectives on Irinotecan Pharmacogenomics
Current and Future Perspectives on Irinotecan Pharmacogenomics. ACPS Clinical Pharmacology Subcommittee 3 November 2004 Luis A. Parodi, PhD - Director and Site Head, Clinical Pharmacogenomics Mark E. Morrison, MD, PhD - Medical Director, Team Leader, Camptosar
392 views • 14 slides